CAJ | 학술논문

异基因造血干细胞移植是惟一有可能治愈多发性骨髓瘤的方法,但其治疗相关死亡率高限制了其应用.自体造血干细胞移植对提高患者的生活质量及延长生存期起到了巨大的作用,近年来各种新药及传统的化疗方案加新药所组成的新的化疗方案的应用更进一步提高了自体造血干细胞移植的疗效.
이기인조혈간세포이식시유일유가능치유다발성골수류적방법,단기치료상관사망솔고한제료기응용.자체조혈간세포이식대제고환자적생활질량급연장생존기기도료거대적작용,근년래각충신약급전통적화료방안가신약소조성적신적화료방안적응용경진일보제고료자체조혈간세포이식적료효.
Allogeneic hematopoietic stem cell transplantation is the only measure which can cure multiple myeloma,but the high mortality rate related with it limited its use.Autologous hematopoietic stem cell transplantation(Auto-HSCT) has made a great contribution at improving the patients' quality of life and prolonging the survival.In recent years,the application of new drugs and new chemotherapy regimen consisted of traditional chemotherapy and new drugs further enhance the curative effect.